20 years of rituximab treatment: what have we learnt?
Future Oncol
; 15(36): 4119-4121, 2019 Dec.
Article
in En
| MEDLINE
| ID: mdl-31718346
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Molecular Targeted Therapy
/
Rituximab
/
Antineoplastic Agents, Immunological
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Future Oncol
Year:
2019
Document type:
Article
Affiliation country: